RxDoctor Payments Data

Haylee Eliasson, NP

Nurse Practitioner · Kenosha, WINPI 1982239786

Payments from drug & device makers

$349in general payments, 2019–2025

Across 10 payments — averaging $34.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$115
  • Boehringer Ingelheim$89
  • Zimmer Biomet$35
  • Orthogenrx Inc.$22
  • Johnson & Johnson$20
  • Otsuka America Pharmaceutical, Inc.$19
  • plus $49 from 3 others

What the payments were for

  • Food & beverage$349100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$349 in reported general payments places this provider in the 80th percentile of 3,478 nurse practitioner providers in Wisconsin.

See all nurse practitioner providers in Wisconsin

Medicare billing

Part B allowed, 2024
$25,240
Medicare patients
169
Services billed
262

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter261$205,896
NucalaMepolizumab13$48,125
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr50$26,165
Breztri AerosphereBudesonide/Glycopyr/Formoterol33$21,223
Breo ElliptaFluticasone/Vilanterol34$16,869
Stiolto RespimatTiotropium Br/Olodaterol Hcl23$11,987
Spiriva RespimatTiotropium Bromide19$10,167
Advair HfaFluticasone Propion/Salmeterol24$7,870
SymbicortBudesonide/Formoterol Fumarate21$5,787
Fluticasone-SalmeterolFluticasone Propion/Salmeterol45$5,153
Atrovent HfaIpratropium Bromide11$5,107
Bevespi AerosphereGlycopyrrolate/Formoterol Fum11$4,599
Albuterol Sulfate HfaAlbuterol Sulfate177$4,335
Roflumilast43$2,689
Wixela InhubFluticasone Propion/Salmeterol22$2,504

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere$115$31,61065 claims
Boehringer IngelheimStiolto Respimat, Spiriva Respimat$89$22,15442 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,478 nurse practitioner providers in Wisconsin.

Other nurse practitioner in Kenosha

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →